Related references
Note: Only part of the references are listed.Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam et al.
LANCET INFECTIOUS DISEASES (2022)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
R. L. Gottlieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A. Fischer et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19)
Stephanie Baggio et al.
CLINICAL INFECTIOUS DISEASES (2021)
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis
Jingjing He et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
Myron M. Levine et al.
CLINICAL INFECTIOUS DISEASES (2021)
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Rafal Butowt et al.
NEUROSCIENTIST (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
Billy J. Quilty et al.
LANCET PUBLIC HEALTH (2021)
Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis
Gopiram Syangtan et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
Dieter Munker et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
Michael Marks et al.
LANCET INFECTIOUS DISEASES (2021)
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness
Ruian Ke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
Min-Chul Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus
Irene Petersen et al.
CLINICAL EPIDEMIOLOGY (2021)
Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza A Clinical Study
Suzanna Paterson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 A Randomized Trial
Andreas Barratt-Due et al.
ANNALS OF INTERNAL MEDICINE (2021)
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Thomas M Drake et al.
LANCET (2021)
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic
Garth Rapeport et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
S. J. Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
Rana Abdelnabi et al.
EBIOMEDICINE (2021)
Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis
Marion Renaud et al.
JAMA NETWORK OPEN (2021)
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period
Ping Yu et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer et al.
ANNALS OF INTERNAL MEDICINE (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Temporal dynamics in viral shedding and transmissibility of COVID-19
Xi He et al.
NATURE MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation
D. Gbesemete et al.
BMC MEDICINE (2020)
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
Marc Baay et al.
BIOLOGICALS (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models
Meagan E. Deming et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment
Jonathan S. Nguyen-Van-Tam et al.
PLOS PATHOGENS (2020)
SARS-CoV-2 detection, viral load and infectivity over the course of an infection
Kieran A. Walsh et al.
JOURNAL OF INFECTION (2020)
Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
Maximillian S. Habibi et al.
SCIENCE (2020)
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
Kirsten Alexandra Eberhardt et al.
VIRUSES-BASEL (2020)
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
Ash K. Clift et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber et al.
NATURE COMMUNICATIONS (2020)
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
Kyle Rosenke et al.
EMERGING MICROBES & INFECTIONS (2020)
RSV-specific airway resident memory CD8+T cells and differential disease severity after experimental human infection
Agnieszka Jozwik et al.
NATURE COMMUNICATIONS (2015)
Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals
Bindiya Bagga et al.
ANTIVIRAL THERAPY (2013)
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
John P. DeVincenzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)